Report - Annual Report and Accounts 2018 - silence-therapeutics.com · Beta-Thalassemia – CTA filed Q1 2019 • – First patients expected to enter a Phase Ib study in H2 2019 Advanced

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form